• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dasatinib induced pleuro-pericardial effusion.

作者信息

Mishra Ajay Kumar, Sahu Kamal Kant, Kaul Sudesh, Lal Amos

机构信息

Department of Internal Medicine Saint Vincent Hospital Worcester, Massachusetts USA, 01608.

Saint Vincent Hospital, Worcester, MA.

出版信息

Acta Biomed. 2020 Mar 19;91(1):142-143. doi: 10.23750/abm.v91i1.8914.

DOI:10.23750/abm.v91i1.8914
PMID:32191670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7569591/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/7569591/8d8042e88575/ACTA-91-142-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/7569591/8d8042e88575/ACTA-91-142-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/7569591/8d8042e88575/ACTA-91-142-g001.jpg

相似文献

1
Dasatinib induced pleuro-pericardial effusion.达沙替尼诱发了胸膜心包积液。
Acta Biomed. 2020 Mar 19;91(1):142-143. doi: 10.23750/abm.v91i1.8914.
2
[Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].达沙替尼治疗伊马替尼耐药的BCR/ABL阳性白血病的疗效
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):581-6. doi: 10.7534/j.issn.1009-2137.2013.03.009.
3
Dasatinib induced pleural effusions - Reply.达沙替尼引起的胸腔积液——回复
Acta Biomed. 2020 Mar 19;91(1):144-145. doi: 10.23750/abm.v91i1.9263.
4
Asymptomatic pericardial effusion in chronic myelogenous leukemia.慢性粒细胞白血病中的无症状心包积液
Leuk Lymphoma. 2003 Apr;44(4):723-5. doi: 10.1080/1042819021000047029.
5
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
6
Benign pericardial effusion in the course of chronic myelogenous leukemia.慢性粒细胞白血病病程中的良性心包积液
Blood. 1950 Oct;5(10):916-9.
7
Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells.达沙替尼和伊马替尼耐药的慢性粒细胞白血病细胞的特征。
Clin Cancer Res. 2008 Oct 1;14(19):6181-6. doi: 10.1158/1078-0432.CCR-08-0461.
8
Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.伏立诺他（辛二酰苯胺异羟肟酸）与达沙替尼（BMS-354825）联合治疗可增强达沙替尼对甲磺酸伊马替尼敏感或甲磺酸伊马替尼耐药的慢性粒细胞白血病细胞的活性。
Clin Cancer Res. 2006 Oct 1;12(19):5869-78. doi: 10.1158/1078-0432.CCR-06-0980.
9
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management.达沙替尼治疗的慢性期慢性髓性白血病患者的胸腔积液：识别与管理
Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):78-82. doi: 10.1016/j.clml.2016.09.012. Epub 2016 Sep 17.
10
Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.达沙替尼治疗慢性期慢性髓性白血病儿科患者的疗效：来自 II 期试验的结果。
J Clin Oncol. 2018 May 1;36(13):1330-1338. doi: 10.1200/JCO.2017.75.9597. Epub 2018 Mar 2.

引用本文的文献

1
Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment.癌症患者的心包疾病：诊断与治疗的临床见解
Cancers (Basel). 2024 Oct 12;16(20):3466. doi: 10.3390/cancers16203466.
2
Therapeutic advances of targeting receptor tyrosine kinases in cancer.靶向治疗癌症受体酪氨酸激酶的治疗进展。
Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w.
3
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management.酪氨酸激酶抑制剂在癌症治疗中的不良反应：病理生理学、机制和临床管理。

本文引用的文献

1
Latent Tuberculosis Infection: Treatment Initiation and Completion Rates in Persons Seeking Immigration and Health Care Workers.潜伏性结核感染：寻求移民和医护人员的感染者的治疗启动和完成率。
Am J Med. 2019 Nov;132(11):1353-1355. doi: 10.1016/j.amjmed.2019.04.036. Epub 2019 May 31.
2
Recurrent Pulmonary Embolism and Hypersensitivity Pneumonitis Secondary to Aspergillus, in a Compost Plant Worker: Case Report and Review of Literature.复发性肺栓塞和变应性细支气管炎继发于曲霉菌，在堆肥厂工人中：病例报告和文献复习。
Lung. 2018 Oct;196(5):553-560. doi: 10.1007/s00408-018-0142-6. Epub 2018 Jul 19.
3
Rare Cause of Respiratory Failure: A Twist in the Tale.
Signal Transduct Target Ther. 2023 Jul 7;8(1):262. doi: 10.1038/s41392-023-01469-6.
4
Dasatinib-Induced Bilateral Pleural Effusions.达沙替尼诱发双侧胸腔积液。
Cureus. 2022 Apr 7;14(4):e23906. doi: 10.7759/cureus.23906. eCollection 2022 Apr.
5
Dasatinib-Induced Pleural and Pericardial Effusions.达沙替尼引起的胸腔和心包积液。
Cureus. 2021 Oct 25;13(10):e19024. doi: 10.7759/cureus.19024. eCollection 2021 Oct.
呼吸衰竭的罕见病因：故事中的转折
Ann Am Thorac Soc. 2018 Jul;15(7):880-883. doi: 10.1513/AnnalsATS.201802-122CC.
4
An uncommon case of chronic myeloid leukemia with variant cytogenetic.一例罕见的伴有细胞遗传学变异的慢性髓性白血病。
Acta Biomed. 2018 Apr 3;89(3-S):28-32. doi: 10.23750/abm.v89i3-S.7217.
5
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management.达沙替尼治疗的慢性期慢性髓性白血病患者的胸腔积液：识别与管理
Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):78-82. doi: 10.1016/j.clml.2016.09.012. Epub 2016 Sep 17.
6
Recurrent pericardial effusion and tamponade in a patient with Erdheim-Chester disease (ECD).一名患有厄尔德海姆-切斯特病（ECD）的患者出现复发性心包积液和心包填塞。
BMJ Case Rep. 2015 Nov 24;2015:bcr2015212483. doi: 10.1136/bcr-2015-212483.
7
Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.酪氨酸激酶抑制剂相关的慢性髓性白血病心血管毒性
J Clin Oncol. 2015 Dec 10;33(35):4210-8. doi: 10.1200/JCO.2015.62.4718. Epub 2015 Sep 14.